Turner, M. R., Osei-Lah, A. D., Hammers, A., Al-Chalabi, A., Shaw, C. E.
, Andersen, P. M., Brooks, D. J., Leigh, P. N. & Mills, K. R. (2005).
Abnormal cortical excitability in sporadic but not homozygous D90A SOD1 ALS.
Journal of Neurology, Neurosurgery and Psychiatry,
76(9), 1279-1285.
https://doi.org/10.1136/jnnp.2004.054429
Isaacs, J. D., Rakshi, J., Baker, R.
, Brooks, D. J. & Warrens, A. N. (2005).
Chorea associated with thyroxine replacement therapy.
Movement Disorders,
20(12), 1656-1657.
https://doi.org/10.1002/mds.20603
Landau, A., Luk, K. C., Jones, M-L., Siegrist-Johnstone, R., Young, Y. K., Kouassi, E., Rymar, V. V., Dagher, A., Sadikot, A. F. & Desbarats, J. (2005).
Defective Fas expression exacerbates neurotoxicity in a model of Parkinson's disease.
Journal of Experimental Medicine,
202(5), 575-81.
https://doi.org/10.1084/jem.20050163
Remy, P., Doder, M., Lees, A., Turjanski, N.
& Brooks, D. (2005).
Depression in Parkinson's disease: Loss of dopamine and noradrenaline innervation in the limbic system.
Brain,
128(6), 1314-1322.
https://doi.org/10.1093/brain/awh445
Turner, M. R., Hammers, A., Al-Chalabi, A., Shaw, C. E.
, Andersen, P. M., Brooks, D. J. & Leigh, P. N. (2005).
Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: Studies with [11C]flumazenil PET.
Brain,
128(6), 1323-1329.
https://doi.org/10.1093/brain/awh509
Khan, N. L., Scherfler, C., Graham, E., Bhatia, K. P., Quinn, N., Lees, A. J.
, Brooks, D. J., Wood, N. W. & Piccini, P. (2005).
Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single parkin mutation.
Neurology,
64(1), 134-136.
https://doi.org/10.1212/01.WNL.0000148725.48740.6D
Piccini, P.
, Pavese, N., Hagell, P., Reimer, J., Björklund, A., Oertel, W. H., Quinn, N. P.
, Brooks, D. J. & Lindvall, O. (2005).
Factors affecting the clinical outcome after neural transplantation in Parkinson's disease.
Brain,
128(12), 2977-2986.
https://doi.org/10.1093/brain/awh649
Lingford-Hughes, A. R., Wilson, S. J., Cunningham, V. J., Feeney, A., Stevenson, B.
, Brooks, D. J. & Nutt, D. J. (2005).
GABA-benzodiazepine receptor function in alcohol dependence: A combined 11C-flumazenil PET and pharmacodynamic study.
Psychopharmacology,
180(4), 595-606.
https://doi.org/10.1007/s00213-005-2271-x
Ros, R., Garre, P. G., Hirano, M., Tai, Y. F., Ampuero, I., Vidal, L., Rojo, A., Fontan, A., Vazquez, A., Fanjul, S., Hernandez, J., Cantarero, S., Hoenicka, J., Jones, A., Ahsan, R. L.
, Pavese, N., Piccini, P.
, Brooks, D. J., Perez-Tur, J. ... De Yébenes, J. G. (2005).
Genetic linkage of autosomal dominant progressive supranuclear palsy to 1q31.1.
Annals of Neurology,
57(5), 634-641.
https://doi.org/10.1002/ana.20449
Love, S., Plaha, P., Patel, N. K., Hotton, G. R.
, Brooks, D. J. & Gill, S. S. (2005).
Glial cell line-derived neurotrophic factor induces neuronal sprouting in human brain.
Nature Medicine,
11(7), 703-704.
https://doi.org/10.1038/nm0705-703
Linnet, J., Gjedde, A., Kumakura, Y.
, Cumming, P. & Møller, A. (2005).
High sensation seeking men have increased dopamine release in the right putamen during gambling. Poster session presented at High sensation seeking men have increased dopamine release in the right putamen during gambling, Washington DC, United States.
Cheesman, A. L., Barker, R. A., Lewis, S. J. G., Robbins, T. W., Owen, A. M.
& Brooks, D. J. (2005).
Lateralisation of striatal function: Evidence from 18F-dopa PET in Parkinson's disease.
Journal of Neurology, Neurosurgery and Psychiatry,
76(9), 1204-1210.
https://doi.org/10.1136/jnnp.2004.055079
Chaudhuri, K. R., Buxton-Thomas, M., Dhawan, V., Peng, R., Meilak, C.
& Brooks, D. J. (2005).
Long duration asymmetrical postural tremor is likely to predict development of Parkinson's disease and not essential tremor: Clinical follow up study of 13 cases.
Journal of Neurology, Neurosurgery and Psychiatry,
76(1), 115-117.
https://doi.org/10.1136/jnnp.2004.046292
Turner, M. R., Gerhard, A., Al-Chalabi, A., Shaw, C. E., Hughes, R. A. C., Banati, R. B.
, Brooks, D. J. & Leigh, P. N. (2005).
Mills' and other isolated upper motor neurone syndromes: In vivo study with 11C-(R)-PK11195 PET.
Journal of Neurology, Neurosurgery and Psychiatry,
76(6), 871-874.
https://doi.org/10.1136/jnnp.2004.047902
Khan, N. L., Jain, S., Lynch, J. M.
, Pavese, N., Abou-Sleiman, P., Holton, J. L., Healy, D. G., Gilks, W. P., Sweeney, M. G., Ganguly, M., Gibbons, V., Gandhi, S., Vaughan, J., Eunson, L. H., Katzenschlager, R., Gayton, J., Lennox, G., Revesz, T., Nicholl, D. ... Wood, N. W. (2005).
Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: Clinical, pathological, olfactory and functional imaging and genetic data.
Brain,
128(12), 2786-2796.
https://doi.org/10.1093/brain/awh667
Rascol, O.
, Brooks, D. J., Melamed, E., Oertel, W., Poewe, W., Stocchi, F. & Tolosa, E. (2005).
Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): A randomised, double-blind, parallel-group trial.
Lancet,
365(9463), 947-954.
https://doi.org/10.1016/S0140-6736(05)71083-7
Von Spiczak, S., Whone, A. L., Hammers, A., Asselin, M. C., Turkheimer, F., Tings, T., Happe, S., Paulus, W., Trenkwalder, C.
& Brooks, D. J. (2005).
The role of opioids in restless legs syndrome: An [11C] diprenorphine PET study.
Brain,
128(4), 906-917.
https://doi.org/10.1093/brain/awh441
Ravina, B., Eidelberg, D., Ahlskog, J. E., Albin, R. L.
, Brooks, D. J., Carbon, M., Dhawan, V., Feigin, A., Fahn, S., Guttman, M., Gwinn-Hardy, K., McFarland, H., Innis, R., Katz, R. G., Kieburtz, K., Kish, S. J., Lange, N., Langston, J. W., Marek, K. ... Holloway, R. (2005).
The role of radiotracer imaging in Parkinson disease.
Neurology,
64(2), 208-215.
https://doi.org/10.1212/01.WNL.0000149403.14458.7F
Brooks, D. J., Agid, Y., Eggert, K., Widner, H.
, Østergaard, K. & Holopainen, A. (2005).
Treatment of end-of-dose wearing-off in Parkinson's disease: Stalevo® (levodopa/carbidopa/entacapone) and levodopa/DDCI given in combination with Comtess®/Comtan® (entacapone) provide equivalent improvements in symptom control superior to that of traditional levodopa/DDCI treatment.
European Neurology,
53(4), 197-202.
https://doi.org/10.1159/000086479
Melichar, J. K., Hume, S. P., Williams, T. M., Daglish, M. R. C., Taylor, L. G., Ahmad, R., Malizia, A. L.
, Brooks, D. J., Myles, J. S., Lingford-Hughes, A. & Nutt, D. J. (2005).
Using [11C]diprenorphine to image opioid receptor occupancy by methadone in opioid addiction: Clinical and preclinical studies.
Journal of Pharmacology and Experimental Therapeutics,
312(1), 309-315.
https://doi.org/10.1124/jpet.104.072686
Turner, M. R., Rabiner, E. A., Hammers, A., Al-Chalabi, A., Grasby, P. M., Shaw, C. E.
, Brooks, D. J. & Leigh, P. N. (2005).
[11C]-WAY100635 PET demonstrates marked 5-HT1A receptor changes in sporadic ALS.
Brain,
128(4), 896-905.
https://doi.org/10.1093/brain/awh428
Whone, A. L., Bailey, D. L., Remy, P.
, Pavese, N. & Brooks, D. J. (2004).
A technique for standardized central analysis of 6-18F-fluoro-L- DOPA PET data from a multicenter study.
Journal of Nuclear Medicine,
45(7), 1135-1145.
Pavese, N., Rimoldi, O., Gerhard, A.
, Brooks, D. J. & Piccini, P. (2004).
Cardiovascular effects of methamphetamine in Parkinson's disease patients.
Movement Disorders,
19(3), 298-303.
https://doi.org/10.1002/mds.10651
Wenning, G. K., Tison, F., Seppi, K., Sampiao, C., Diem, A., Yekhlef, F., Ghorayeb, I., Ory, F., Galitzky, M., Scaravilli, T., Bozi, M., Colosimo, C., Gilman, S., Shults, C. W., Quinn, N. P., Rascol, O., Poewe, W.
, Dupont, E., Ostergaard, K. ... Bergquist, J. (2004).
Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS).
Movement Disorders,
19(12), 1391-1402.
https://doi.org/10.1002/mds.20255
Turner, M. R., Cagnin, A., Turkheimer, F. E., Miller, C. C. J., Shaw, C. E.
, Brooks, D. J., Leigh, P. N. & Banati, R. B. (2004).
Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: An [11C](R)-PK11195 positron emission tomography study.
Neurobiology of Disease,
15(3), 601-609.
https://doi.org/10.1016/j.nbd.2003.12.012
Gerhard, A., Watts, J., Trender-Gerhard, I., Turkheimer, F., Banati, R. B., Bhatia, K.
& Brooks, D. J. (2004).
In vivo imaging of microglial activation with [11C](R -PK11195 PET in corticobasal degeneration.
Movement Disorders,
19(10), 1221-1226.
https://doi.org/10.1002/mds.20162
Whone, A. L., Von Spiczak, S., Edwards, M., Valente, E. M., Hammers, A., Bhatia, K. P.
& Brooks, D. J. (2004).
Opioid binding in DYT1 primary torsion dystonia: An 11C-diprenorphine PET study.
Movement Disorders,
19(12), 1498-1503.
https://doi.org/10.1002/mds.20238
Scherfler, C.
, Khan, N. L., Pavese, N., Eunson, L., Graham, E., Lees, A. J., Quinn, N. P., Wood, N. W.
, Brooks, D. J. & Piccini, P. P. (2004).
Striatal and cortical pre- and postsynaptic dopaminergic dysfunction in sporadic parkin-linked parkinsonism.
Brain,
127(6), 1332-1342.
https://doi.org/10.1093/brain/awh150
Tai, Y. F., Scherfler, C.
, Brooks, D. J., Sawamoto, N. & Castiello, U. (2004).
The Human Premotor Cortex Is 'Mirror' only for Biological Actions.
Current Biology,
14(2), 117-120.
https://doi.org/10.1016/j.cub.2004.01.005
Brooks, D. J., Frey, K. A., Marek, K. L., Oakes, D., Paty, D., Prentice, R., Shults, C. W. & Stoessl, A. J. (2003).
Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease.
Experimental Neurology,
184(SUPPL. 1).
https://doi.org/10.1016/j.expneurol.2003.08.008
Gill, S. S., Patel, N. K., Hotton, G. R., O'Sullivan, K., McCarter, R., Bunnage, M.
, Brooks, D. J., Svendsen, C. N. & Heywood, P. (2003).
Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease.
Nature Medicine,
9(5), 589-595.
https://doi.org/10.1038/nm850
Goerendt, I. K., Messa, C., Lawrence, A. D., Grasby, P. M., Piccini, P.
& Brooks, D. J. (2003).
Dopamine release during sequential finger movements in health and Parkinson's disease: A PET study.
Brain,
126(2), 312-325.
https://doi.org/10.1093/brain/awg035
Hammers, A., Koepp, M. J., Richardson, M. P., Hurlemann, R.
, Brooks, D. J. & Duncan, J. S. (2003).
Grey and white matter flumazenil binding in neocortical epilepsy with normal MRI. A PET study of 44 patients.
Brain,
126(6), 1300-1318.
https://doi.org/10.1093/brain/awg138
Pavese, N., Andrews, T. C.
, Brooks, D. J., Ho, A. K., Rosser, A. E., Barker, R. A., Robbins, T. W., Sahakian, B. J., Dunnett, S. B. & Piccini, P. (2003).
Progressive striatal and cortical dopamine receptor dysfunction in Huntington's disease: A pet study.
Brain,
126(5), 1127-1135.
https://doi.org/10.1093/brain/awg119
Whone, A. L., Watts, R. L., Stoessl, A. J., Davis, M., Reske, S., Nahmias, C., Lang, A. E., Rascol, O.
, Ribeiro, M. J., Remy, P., Poewe, W. H., Hauser, R. A.
& Brooks, D. J. (2003).
Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.
Annals of Neurology,
54(1), 93-101.
https://doi.org/10.1002/ana.10609
Hammers, A., Allom, R., Koepp, M. J., Free, S. L., Myers, R., Lemieux, L., Mitchell, T. N.
, Brooks, D. J. & Duncan, J. S. (2003).
Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe.
Human Brain Mapping,
19(4), 224-247.
https://doi.org/10.1002/hbm.10123
Doder, M., Rabiner, E. A., Turjanski, N., Lees, A. J.
& Brooks, D. J. (2003).
Tremor in Parkinson's disease and serotonergic dysfunction: An 11C-WAY 100635 PET study.
Neurology,
60(4), 601-605.
https://doi.org/10.1212/01.WNL.0000031424.51127.2B
Gerhard, A., Banati, R. B., Goerres, G. B., Cagnin, A., Myers, R., Gunn, R. N., Turkheimer, F., Good, C. D., Mathias, C. J., Quinn, N.
, Schwarz, J. & Brooks, D. J. (2003).
[11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy.
Neurology,
61(5), 686-689.
https://doi.org/10.1212/01.WNL.0000078192.95645.E6
Berding, G., Brücke, T., Odin, P.
, Brooks, D. J., Kolbe, H., Gielow, P., Harke, H., Knoop, B. O., Dengler, R. & Knapp, W. H. (2003).
[123I]β-CIT SPECT imaging of dopamine and serotonin transporters in Parkinson's disease and multiple system atrophy.
Nuklearmedizin,
42(1), 31-38.
Ceravolo, R., Piccini, P., Bailey, D. L., Jorga, K. M., Bryson, H.
& Brooks, D. J. (2002).
18F-dopa PET evidence that tolcapone acts as a central COMT inhibitor in Parkinson's disease.
Synapse,
43(3), 201-207.
https://doi.org/10.1002/syn.10034
Boecker, H., Ceballos-Baumann, A. O., Bartenstein, P., Dagher, A., Forster, K., Haslinger, B.
, Brooks, D. J., Schwaiger, M. & Conrad, B. (2002).
A H2 15O positron emission tomography study on mental imagery of movement sequences - The effect of modulating sequence length and direction.
NeuroImage,
17(2), 999-1009.
https://doi.org/10.1016/S1053-8119(02)91139-0
Rakshi, J. S.
, Pavese, N., Uema, T.
, Ito, K., Morrish, P. K., Bailey, D. L.
& Brooks, D. J. (2002).
A comparison of the progression of early Parkinson's disease in patients started on ropinirole or L-dopa: An 18F-dopa PET study.
Journal of Neural Transmission,
109(12), 1433-1443.
https://doi.org/10.1007/s00702-002-0753-0
Brunt, E. R.
, Brooks, D. J., Korczyn, A. D., Montastruc, J. L. & Stocchi, F. (2002).
A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by L-dopa.
Journal of Neural Transmission,
109(4), 489-502.
https://doi.org/10.1007/s007020200040
Hammers, A., Koepp, M. J., Hurlemann, R., Thom, M., Richardson, M. P.
, Brooks, D. J. & Duncan, J. S. (2002).
Abnormalities of grey and white matter [11C]flumazenil binding in temporal lobe epilepsy with normal MRI.
Brain,
125(10), 2257-2271.
https://doi.org/10.1093/brain/awf233
Hu, M. T. M., Chaudhuri, K. R., Jorosz, J., Yaguez, L.
& Brooks, D. J. (2002).
An imaging study of parkinsonism among African-Caribbean and Indian London communities.
Movement Disorders,
17(6), 1321-1328.
https://doi.org/10.1002/mds.10261
Khan, N. L., Valente, E. M., Bentivoglio, A. R., Wood, N. W., Albanese, A.
, Brooks, D. J. & Piccini, P. (2002).
Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: An 18F-dopa PET study.
Annals of Neurology,
52(6), 849-853.
https://doi.org/10.1002/ana.10417
Hagell, P., Piccini, P., Björklund, A., Brundin, P., Rehncrona, S., Widner, H., Crabb, L.
, Pavese, N., Oertel, W. H., Quinn, N.
, Brooks, D. J. & Lindvall, O. (2002).
Dyskinesias following neural transplantation in parkinson’s disease.
Nature Neuroscience,
5(7), 627-628.
https://doi.org/10.1038/nn863
Johansen, J., Rosenblad, C., Andsberg, K.
, Møller, A., Lundberg, C., Björlund, A. & Johansen, TE. (2002).
Evaluation on Tet-on system to avoid transgene downregulation in ex vivo gene transfer to the CNS.
Gene Therapy,
9, 1291-1301.
Leigh, P. N., Simmons, A., Williams, S., Williams, V., Turner, M.
& Brooks, D. (2002).
Imaging: MRS/MRI/PET/SPECT: Summary.
Amyotrophic Lateral Sclerosis and other Motor Neuron Disorders,
3(SUPPL. 1).
Lingford-Hughes, A., Hume, S. P., Feeney, A., Hirani, E., Osman, S., Cunningham, V. J., Pike, V. W.
, Brooks, D. J. & Nutt, D. J. (2002).
Imaging the GABA-benzodiazepine receptor subtype containing the α-5-subunit in vivo with [11C]Ro15 4513 positron emission tomography.
Journal of Cerebral Blood Flow and Metabolism,
22(7), 878-889.
https://doi.org/10.1097/00004647-200207000-00013
Hammers, A., Koepp, M. J., Free, S. L., Brett, M., Richardson, M. P., Labbé, C., Cunningham, V. J.
, Brooks, D. J. & Duncan, J. (2002).
Implementation and application of a brain template for multiple volumes of interest.
Human Brain Mapping,
15(3), 165-174.
https://doi.org/10.1002/hbm.10016
Kjaer, T. W.
, Bertelsen, C., Piccini, P.
, Brooks, D., Alving, J. & Lou, H. C. (2002).
Increased dopamine tone during meditation-induced change of consciousness.
Cognitive Brain Research,
13(2), 255-259.
https://doi.org/10.1016/S0926-6410(01)00106-9
Dagø, L., Bonde, C., Peters, D.
, Møller, A., Bomholt, S. F., Hartz, B. P., Meyer, M., Drejer, J. & Grønborg, M. (2002).
NS1231, a novel compound with neurotrophic-like effects in vitro and in vivo.
Neurochemical,
81, 17-24.
Khan, N. L., Brooks, D. J., Pavese, N., Sweeney, M. G., Wood, N. W., Lees, A. J. & Piccini, P. (2002).
Progression of nigrostriatal dysfunction in a parkin kindred: An [18F]dopa PET and clinical study.
Brain,
125(10), 2248-2256.
Dall, A. M.
, Danielsen, E. H., Sørensen, J. C. H., Andersen, F., Møller, A., Zimmer, J.
, Gjedde, A. H. & Cumming, P. (2002).
Quantitative [18F]fluorodopa/PET and histology of fetal mesencephalic dopaminergic grafts to the striatum of MPTP-poisoned minipigs. Cell Transplantation,
11(8), 733-46.
Dall, A. M., Danielsen, E. H., Sørensen, J. C., Andersen, F.
, Møller, A., Zimmer, J., Gjedde, A., the DaNeX Group & Cumming, P. (2002).
Quantitative [18F]Fluorodopa/PET and histology of fetal mesencephalic dopaminergic grafts to the striatum of MPTP-poisoned Minipigs.
Cell Transplantation,
11, 733-746.
Ito, K., Nagano-Saito, A., Kato, T., Arahata, Y., Nakamura, A., Kawasumi, Y., Hatano, K., Abe, Y., Yamada, T., Kachi, T.
& Brooks, D. J. (2002).
Striatal and extrastriatal dysfunction in Parkinson's disease with dementia: A 6-[18F]fluoro-L-dopa PET study.
Brain,
125(6), 1358-1365.
https://doi.org/10.1093/brain/awf134
Nicholl, D. J., Vaughan, J. R.
, Khan, N. L., Ho, S. L., Aldous, D. E. W., Lincoln, S., Farrer, M., Gayton, J. D.
, Davis, M. B., Piccini, P., Daniel, S. E., Lennox, G. G.
, Brooks, D. J., Williams, A. C. & Wood, N. W. (2002).
Two large British kindreds with familial Parkinson's disease: A clinico-pathological and genetic study.
Brain,
125(1), 44-57.
https://doi.org/10.1093/brain/awf013
Hu, M. T. M., White, S. J., Herlihy, A. H., Chaudhuri, K. R., Hajnal, J. V.
& Brooks, D. J. (2001).
A comparison of 18F-dopa PET and inversion recovery MRI in the diagnosis of parkinson's disease.
Neurology,
56(9), 1195-1200.
https://doi.org/10.1212/WNL.56.9.1195
Hammers, A., Koepp, M. J., Richardson, M. P., Labbé, C.
, Brooks, D. J., Cunningham, V. J. & Duncan, J. S. (2001).
Central benzodiazepine receptors in malformations of cortical development: A quantitative study.
Brain,
124(8), 1555-1565.
Hu, M. T. M., White, S. J., Chaudhuri, K. R., Morris, R. G., Bydder, G. M.
& Brooks, D. J. (2001).
Correlating rates of cerebral atrophy in Parkinson's disease with measures of cognitive decline.
Journal of Neural Transmission,
108(5), 571-580.
https://doi.org/10.1007/s007020170057
Sager, T. N., Topp, S., Torup, L., Egestad, B.
& Møller, A. (2001).
Evaluation of CA1 damage using single-voxel 1H-MRS and un-biased stereology: Can non-invasive measures of N-acetyl-asparate following global ischemia be used as a reliable measure of neuronal damage? Brain Research,
892, 166-175.
Hirani, E., Gillies, J., Karasawa, A., Shimada, J., Kase, H., Opacka-Juffry, J.
, Osman, S., Luthra, S. K., Hume, S. P.
& Brooks, D. J. (2001).
Evaluation of [4-O-methyl-11C]KW-6002 as a potential PET ligand for mapping central adenosine A2A receptors in rats.
Synapse,
42(3), 164-176.
https://doi.org/10.1002/syn.1110
Piccini, P., De Yebenez, J., Lees, A. J., Ceravolo, R., Turjanski, N., Pramstaller, P.
& Brooks, D. J. (2001).
Familial progressive supranuclear palsy: Detection of subclinical cases using 18F-dopa and 18fluorodeoxyglucose positron emission tomography.
Archives of Neurology,
58(11), 1846-1851.
https://doi.org/10.1001/archneur.58.11.1846
Cagnin, A.
, Brooks, D. J., Kennedy, A. M., Gunn, R. N., Myers, R., Turkheimer, F. E., Jones, T. & Banati, R. B. (2001).
In-vivo measurement of activated microglia in dementia.
Lancet,
358(9280), 461-467.
https://doi.org/10.1016/S0140-6736(01)05625-2
Del Dotto, P.
, Pavese, N., Gambaccini, G., Bernardini, S., Metman, L. V., Chase, T. N. & Bonuccelli, U. (2001).
Intravenous amantadine improves levadopa-induced dyskinesias: An acute double-blind placebo-controlled study.
Movement Disorders,
16(3), 515-520.
https://doi.org/10.1002/mds.1112
Banati, R. B., Cagnin, A.
, Brooks, D. J., Gunn, R. N., Myers, R., Jones, T., Birch, R. & Anand, P. (2001).
Long-term trans-synaptic glial responses in the human thalamus after peripheral nerve injury.
NeuroReport,
12(16), 3439-3442.
https://doi.org/10.1097/00001756-200111160-00012
Hammers, A., Koepp, M. J., Labbé, C.
, Brooks, D. J., Thom, M., Cunningham, V. J. & Duncan, J. S. (2001).
Neocortical abnormalities of [11C]-flumazenil PET in mesial temporal lobe epilepsy.
Neurology,
56(7), 897-906.
https://doi.org/10.1212/WNL.56.7.897
Cumming, P., Danielsen, E. H., Vafaee, M., Faldborg, L., Steffensen, E., Sørensen, J. C., Gillings, N., Bender, D., Marthi, K., Andersen, F., Munk, O., Smith, D.
, Møller, A. & Gjedde, A. (2001).
Normalization of markers for dopamine innervation in striatum of MPTP-lesioned miniature pigs with intrastriatal grafts.
Acta Neurologica Scandinavica,
103, 309-315.
Varming, T., Sager, T. N., Mathiesen, C., Johansen, T. H.
, Møller, A., Wätjen, F. & Drejer, J. (2001).
Optimazation of isatine oximes as neuroprotective AMPA receptor antagonist: In vitro and in vivo evaluation of SPD 502. In: Excitatory amino acids: Ten years after.
IOS press.
Berding, G., Odin, P.
, Brooks, D. J., Nikkhah, G., Matthies, C., Peschel, T., Shing, M., Kolbe, H., van den Hoff, J., Fricke, H., Dengler, R., Samii, M. & Knapp, W. H. (2001).
Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [18F]FDG-PET.
Movement Disorders,
16(6), 1014-1022.
https://doi.org/10.1002/mds.1212
Carboncini, M. C., Manzoni, D., Strambi, S., Bonuccelli, U.
, Pavese, N., Andre, P. & Rossi, B. (2001).
The relation between EMG activity and kinematic parameters strongly supports a role of the action tremor in parkinsonian bradykinesia.
Movement Disorders,
16(1), 47-57.
https://doi.org/10.1002/1531-8257(200101)16:1<47::AID-MDS1012>3.0.CO;2-V
Bhatia, K.
, Brooks, D. J., Burn, D. J., Clarke, C. E., Grosset, D. G., MacMahon, D. G., Fer, J. P., Schapira, A. H. V., Stewart, D. & Williams, A. C. (2001).
Updated guidelines for the management of Parlcinson's disease.
Hospital Medicine,
62(8), 456-470.
https://doi.org/10.12968/hosp.2001.62.8.1621
Koepp, M. J., Hammers, A., Labbé, C., Woermann, F. G.
, Brooks, D. J. & Duncan, J. S. (2000).
11C-flumazenil PET in patients with refractory temporal lobe epilepsy and normal MRI.
Neurology,
54(2), 332-339.
Rascol, O.
, Brooks, D. J., Korczyn, A. D., De Deyn, P. P., Clarke, C. E. & Lang, A. E. (2000).
A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa.
New England Journal of Medicine,
342(20), 1484-1491.
https://doi.org/10.1056/NEJM200005183422004
Rønn, L. C. B., Ralets, I., Hartz, B. P., Bech, M., Berezin, A., Berezin, V.
, Møller, A. & Bock, E. (2000).
A simple procedure for quantification of neurite outgrowth based on stereological principles.
Journal of Neuroscience Methods,
100, 25-32.
Brundin, P., Pogarell, O., Hagell, P., Piccini, P., Widner, H., Schrag, A., Kupsch, A., Crabb, L., Odin, P., Gustavii, B., Björklund, A.
, Brooks, D. J., Marsden, C. D., Oertel, W. H., Quinn, N. P., Rehncrona, S. & Lindvall, O. (2000).
Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease.
Brain,
123(7), 1380-1390.
Rogers, R. D., Andrews, T. C., Grasby, P. M.
, Brooks, D. J. & Robbins, T. W. (2000).
Contrasting cortical and subcortical activations produced by attentional-set shifting and reversal learning in humans.
Journal of Cognitive Neuroscience,
12(1), 142-162.
https://doi.org/10.1162/089892900561931
Hu, M. T. M., Taylor-Robinson, S. D., Chaudhuri, K. R., Bell, J. D., Labbé, C., Cunningham, V. J., Koepp, M. J., Hammers, A., Morris, R. G., Turjanski, N.
& Brooks, D. J. (2000).
Cortical dysfunction in non-demented Parkinson's disease patients. A combined 31P-MRS and 18FDG-PET study.
Brain,
123(2), 340-352.
https://doi.org/10.1093/brain/123.2.340
Piccini, P., Lindvall, O., Björklund, A., Brundin, P., Hagell, P., Ceravolo, R., Oertel, W., Quinn, N., Samuel, M., Rehncrona, S., Widner, H.
& Brooks, D. J. (2000).
Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts.
Annals of Neurology,
48(5), 689-695.
https://doi.org/10.1002/1531-8249(200011)48:5<689::AID-ANA1>3.0.CO;2-N
Lloyd, C. M., Richardson, M. P.
, Brooks, D. J., Al-Chalabi, A. & Leigh, P. N. (2000).
Extramotor involvement in ALS: PET studies with the GABA(A) ligand [11C]flumazenil.
Brain,
123(11), 2289-2296.
https://doi.org/10.1093/brain/123.11.2289
Hagell, P., Crabb, L., Pogarell, O., Schrag, A., Widner, H.
, Brooks, D. J., Oertel, W. H., Quinn, N. P. & Lindvall, O. (2000).
Health-related quality of life following bilateral intrastriatal transplantation in Parkinson's disease.
Movement Disorders,
15(2), 224-229.
https://doi.org/10.1002/1531-8257(200003)15:2<224::AID-MDS1004>3.0.CO;2-W
Jalan, R., Turjanski, N., Taylor-Robinson, S. D., Koepp, M. J., Richardson, M. P.
, Wilson, J. A., Bell, J. D.
& Brooks, D. J. (2000).
Increased availability of central benzodiazepine receptors in patients with chronic hepatic encephalopathy and alcohol related cirrhosis.
Gut,
46(4), 546-552.
https://doi.org/10.1136/gut.46.4.546
Reuter, I., Hu, M. T. M., Andrews, T. C.
, Brooks, D. J., Clough, C. & Ray Chaudhuri, K. (2000).
Late onset levodopa responsive Huntington's disease with minimal chorea masquerading as Parkinson plus syndrome.
Journal of Neurology Neurosurgery and Psychiatry,
68(2), 238-241.
https://doi.org/10.1136/jnnp.68.2.238
Banati, R. B., Cagnin, A., Myers, R., Gunn, R. N., Turkheimer, F. E.
, Brooks, D. J. & Jones, T. (2000).
Microglial activation in neurodegenerative diseases: A PET study using [11C](R)-PK11195.
NeuroImage,
11(6 PART II).
Pavese, N., Giannaccini, G., Betti, L., Ferrari, S., Bonanni, E., Bonuccelli, U., Murri, L. & Lucacchini, A. (2000).
Peripheral-type benzodiazepine receptors in human blood cells of patients affected by migraine without aura.
Neurochemistry International,
37(4), 363-368.
https://doi.org/10.1016/S0197-0186(00)00039-5
Jenkins, I. H., Jahanshahi, M., Jueptner, M., Passingham, R. E.
& Brooks, D. J. (2000).
Self-initiated versus externally triggered movements. II. The effect of movement predictability on regional cerebral blood flow.
Brain,
123(6), 1216-1228.
https://doi.org/10.1093/brain/123.6.1216
Danielsen, E. H., Cumming, P., Andersen, F.
, Bender, D., Brevig, T., Falborg, L., Gee, A., Gillings, N. M., Hansen, S. B., Hermansen, F., Johansen, J., Johansen, T. E., Dahl-Jørgensen, A., Jørgensen, H. A., Meyer, M.
, Munk, O. L., Pedersen, E. B., Poulsen, P. H., Rodell, A. B.
... Møller, A. (2000).
The DaNeX Study of Embryonic Mesencephalic Dopaminergic Tissue Grafted to a Minipig model of Parkinson's disease: Preliminary Findings of Effect of MPTP-Poisoning on Striatal Dopaminergic Markers.
Cell Transplantation,
9(2), 247-259.
Piccini, P.
, Brooks, D. J., Korpela, K.
, Pavese, N., Karlsson, M. & Gordin, A. (2000).
The catechol-O-methyltransferase (COMT) inhibitor entacapone enhances the pharmacokinetic and clinical response to Sinemet CR in Parkinson's disease.
Journal of Neurology Neurosurgery and Psychiatry,
68(5), 589-594.
https://doi.org/10.1136/jnnp.68.5.589
White, R. P., Deane, C., Hindley, C., Bloomfield, P. M., Cunningham, V. J., Vallance, P.
, Brooks, D. J. & Markus, H. S. (2000).
The effect of the nitric oxide donor glyceryl trinitrate on global and regional cerebral blood flow in man.
Journal of the Neurological Sciences,
178(1), 23-28.
https://doi.org/10.1016/S0022-510X(00)00357-9
Taylor-Robinson, S. D., Turjanski, N., Bhattacharya, S., Seery, J. P., Sargentoni, J.
, Brooks, D. J., Bryant, D. J. & Cox, I. J. (1999).
A proton magnetic resonance spectroscopy study of the striatum and cerebral cortex in Parkinson's disease.
Metabolic Brain Disease,
14(1), 45-55.
https://doi.org/10.1023/A:1020609530444
Nicolson, R. I., Fawcett, A. J., Berry, E. L., Jenkins, I. H., Dean, P.
& Brooks, D. J. (1999).
Association of abnormal cerebellar activation with motor learning difficulties in dyslexic adults.
Lancet,
353(9165), 1662-1667.
https://doi.org/10.1016/S0140-6736(98)09165-X
Pavese, N., Napolitano, A., De Laco, G., Canapicchi, R., Collavoli, P. L., Lucetti, C., Gambaccini, G. & Bonuccelli, U. (1999).
Clinical outcome and magnetic resonance imaging of carbon monoxide intoxication. A long-term follow-up study.
Italian Journal of Neurological Sciences,
20(3), 171-178.
https://doi.org/10.1007/s100720050028
Piccini, P.
, Brooks, D. J., Björklund, A., Gunn, R. N., Grasby, P. M., Rimoldi, O., Brundin, P., Hagell, P., Rehncrona, S., Widner, H. & Lindvall, O. (1999).
Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient.
Nature Neuroscience,
2(12), 1137-1140.
https://doi.org/10.1038/16060
Hu, M. T. M., Taylor-Robinson, S. D., Ray Chaudhuri, K., Bell, J. D., Morris, R. G., Clough, C.
, Brooks, D. J. & Turjanski, N. (1999).
Evidence for cortical dysfunction in clinically non-demented patients with Parkinson's disease: A proton MR spectroscopy study.
Journal of Neurology Neurosurgery and Psychiatry,
67(1), 20-26.
https://doi.org/10.1136/jnnp.67.1.20
Rakshi, J. S., Uema, T., Ito, K., Bailey, D. L., Morrish, P. K., Ashburner, J., Dagher, A., Jenkins, I. H., Friston, K. J.
& Brooks, D. J. (1999).
Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease. A 3D [18F]dopa-PET study.
Brain,
122(9), 1637-1650.
https://doi.org/10.1093/brain/122.9.1637
Andrews, T. C., Weeks, R. A., Turjanski, N., Gunn, R. N., Watkins, L. H. A., Sahakian, B., Hodges, J. R., Rosser, A. E., Wood, N. W.
& Brooks, D. J. (1999).
Huntington's disease progression. PET and clinical observations.
Brain,
122(12), 2353-2363.
https://doi.org/10.1093/brain/122.12.2353
Hamdy, S., Rothwell, J. C.
, Brooks, D. J., Bailey, D., Aziz, Q. & Thompson, D. G. (1999).
Identification of the cerebral loci processing human swallowing with H2 15O PET activation.
Journal of Neurophysiology,
81(4), 1917-1926.
https://doi.org/10.1152/jn.1999.81.4.1917
Bonuccelli, U.
, Pavese, N., Lucetti, C., Renna, M. R., Gambaccini, G., Bernardini, S., Canapicchi, R., Carrozzi, L. & Murri, L. (1999).
Late whiplash syndrome: A clinical and magnetic resonance imaging study.
Functional Neurology,
14(4), 219-225.
Mikkelsen, M.
, Møller, A., Jensen, L. H., Pedersen, A., Harajehi, J. B. & Pakkenberg, H. (1999).
MPTP-Induced parkinsonism in Minipigs: A behavioral, biochemical and histological study.
Neurotoxicology and Teratology,
21, 169-175.
Grønborg, M., Johansen, T. E., Peters, D., Ahring, P. K., Drejer, J.
, Møller, A. & Jensen, L. H. (1999).
Neuroprotection by a novel compound, NS5211.
The Journal of Pharmacology and Experimental Therapeutics,
290, 348-353.
Boecker, H., Ceballos-Baumann, A. O., Bartenstein, P., Siebner, H. R., Forster, K., Dagher, A., Haslinger, B.
, Brooks, D. J. & Conrad, B. (1999).
PET imaging of motor sequence control: Pure motor imagination of increasingly complex finger sequences, A parametric 3D H2
15O PET study.
NeuroImage,
9(6 PART II).
Marazziti, D., Toni, C., Pedri, S., Bonuccelli, U.
, Pavese, N., Lucetti, C., Nuti, A., Muratorio, A. & Cassano, G. B. (1999).
Prevalence of headache syndromes in panic disorder.
International Clinical Psychopharmacology,
14(4), 247-251.
https://doi.org/10.1097/00004850-199907000-00007
Gillies, J., Luthra, S. K., Brady, F., Karasawa, A., Shimada, J., Kase, H.
& Brooks, D. J. (1999).
Radiolabelling of KW-6002 with [11C]iodomethane for studies of the adenosine A(2A) receptor in vivo.
Journal of Labelled Compounds and Radiopharmaceuticals,
42(SUPPL. 1).
Nielsen, E. Ø., Warming, T., Mathiesen, C., Jensen, L. H.
, Møller, A., Gouliaev, A. H., Wätjen, F. & Drejer, J. (1999).
SPD 502: A water-soluble and in vivo long-lasting AMPA antagonisk with neuroprotective activity.
The Journal of Pharmacology and Experimental Therapeutics,
289, 1492-1501.
Hagell, P., Schrag, A., Piccini, P., Jahanshahi, M.
, Brown, R., Rehncrona, S., Widner, H., Brundin, P., Rothwell, J. C., Odin, P., Wenning, G. K., Morrish, P., Gustavii, B., Björklund, A.
, Brooks, D. J., Marsden, C. D., Quinn, N. P. & Lindvall, O. (1999).
Sequential bilateral transplantation in Parkinson's disease. Effects of the second graft.
Brain,
122(6), 1121-1132.
https://doi.org/10.1093/brain/122.6.1121
Ito, K., Morrish, P. K., Rakshi, J. S., Uema, T., Ashburner, J., Bailey, D. L., Friston, K. J.
& Brooks, D. J. (1999).
Statistical parametric mapping with 18F-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson's disease.
Journal of Neurology Neurosurgery and Psychiatry,
66(6), 754-758.
https://doi.org/10.1136/jnnp.66.6.754
Cintra, A., Aguirre, J. A., Finnman, U-B., Hagman, M., Agnati, L. F., Höglund, C.
, Møller, A. & Fuxe, K. (1999).
Subchronic toluene exposure in low concentrations produces signs of reduced dysfunction in the 6-hydroxydopamine lesioned nigrostriatal dopaminergic system of the rat.
Neuroscience Letter,
274, 5-8.
White, R. P., Hindley, C., Bloomfield, P. M., Cunningham, V. J., Vallance, P.
, Brooks, D. J. & Markus, H. S. (1999).
The effect of the nitric oxide synthase inhibitor L-NMMA on basal CBF and vasoneuronal coupling in man: A PET study.
Journal of Cerebral Blood Flow and Metabolism,
19(6), 673-678.
https://doi.org/10.1097/00004647-199906000-00011
Piccini, P., Burn, D. J., Ceravolo, R., Maraganore, D.
& Brooks, D. J. (1999).
The role of inheritance in sporadic Parkinson's disease: Evidence from a longitudinal study of dopaminergic function in twins.
Annals of Neurology,
45(5), 577-582.
https://doi.org/10.1002/1531-8249(199905)45:5<577::AID-ANA5>3.0.CO;2-O
Bonuccelli, U., D'Avino, C., Caraccio, N., Del Guerra, P., Casolaro, A.
, Pavese, N., Del Dotto, P. & Monzani, F. (1999).
Thyroid function and autoimmunity in Parkinson's disease: A study of 101 patients.
Parkinsonism and Related Disorders,
5(1-2), 49-53.
https://doi.org/10.1016/S1353-8020(99)00010-3
Schrag, A., Samuel, M., Caputo, E., Scaravilli, T., Troyer, M., Marsden, C. D.
, Thomas, D. G. T., Lees, A. J.
, Brooks, D. J. & Quinn, N. P. (1999).
Unilateral pallidotomy for Parkinson's disease: Results after more than 1 year.
Journal of Neurology Neurosurgery and Psychiatry,
67(4), 511-517.
https://doi.org/10.1136/jnnp.67.4.511
Banati, R. B., Goerres, G. W., Myers, R., Gunn, R. N., Turkheimer, F. E., Kreutzberg, G. W.
, Brooks, D. J., Jones, T. & Duncan, J. S. (1999).
[11C] (R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis.
Neurology,
53(9), 2199-2203.
Brooks, D. J., Abbott, R. J., Lees, A. J., Martignoni, E., Philcox, D. V., Rascol, O., Roos, R. A. C. & Sagar, H. J. (1998).
A placebo-controlled evaluation of ropinirole, a novel D2 agonist, as sole dopaminergic therapy in Parkinson's disease.
Clinical Neuropharmacology,
21(2), 101-107.
Samuel, M., Caputo, E.
, Brooks, D. J., Schrag, A., Scaravilli, T., Branston, N. M., Rothwell, J. C., Marsden, C. D.
, Thomas, D. G. T., Lees, A. J. & Quinn, N. P. (1998).
A study of medial pallidotomy for Parkinson's disease: Clinical outcome, MRI location and complications.
Brain,
121(1), 59-75.
https://doi.org/10.1093/brain/121.1.59
Richardson, M. P., Koepp, M. J.
, Brooks, D. J., Coull, J. T., Grasby, P., Fish, D. R. & Duncan, J. S. (1998).
Cerebral activation in malformations of cortical development.
Brain,
121(7), 1295-1304.
https://doi.org/10.1093/brain/121.7.1295
Koepp, M. J.
, Hansen, M. L., Pressler, R. M.
, Brooks, D. J., Brandl, U., Guldin, B., Duncan, J. S. & Ried, S. (1998).
Comparison of EEG, MRI and PET in reading epilepsy: A case report.
Epilepsy Research,
29(3), 251-257.
Deuschl, G., Bain, P., Brin, M., Agid, Y., Benabid, L., Benecke, R., Berardelli, A.
, Brooks, D. J., Elble, R., Fahn, S., Findley, L. J., Hallett, M., Jankovic, J., Koller, W. C., Krack, P., Lang, A. E., Lees, A., Lucking, C. H., Marsden, C. D. ... Toloso, E. (1998).
Consensus statement of the Movement Disorder Society on tremor.
Movement Disorders,
13(SUPPL. 3), 2-23.
Boecker, H., Dagher, A., Ceballos-Baumann, A. O., Passingham, R. E., Samuel, M., Friston, K. J., Poline, J. B., Dettmers, C., Conrad, B.
& Brooks, D. J. (1998).
Erratum: Role of the human rostral supplementary motor area and the basal ganglia in motor sequence control: Investigations with H2 15O PET (Journal of Neurophysiology (February 1998) 79 (1070-1080)).
Journal of Neurophysiology,
79(4).
Grasby, P. M., Koepp, M. J., Gunn, R. N., Cunningham, V. J., Lawrence, A. D., Dagher, A., Jones, T.
, Brooks, D. J. & Bench, C. J. (1998).
Evidence for dopamine release during a videogame using [11C]Raclopride PET.
NeuroImage,
7(4 PART II).
Samuel, M., Williams, S. C. R., Leigh, P. N., Simmons, A., Chakraborti, S., Andrew, C. M., Fristen, K. J., Goldstein, L. H.
& Brooks, D. J. (1998).
Exploring the temporal nature of hemodynamic responses of cortical motor areas using functional MRI.
Neurology,
51(6), 1567-1575.
https://doi.org/10.1212/WNL.51.6.1567
Lucetti, C., Nuti, A.
, Pavese, N., Gambaccini, G., Rossi, G. & Bonuccelli, U. (1998).
Flunarizine in migraine prophylaxis: Predictive factors for a positive response.
Cephalalgia,
18(6), 349-352.
https://doi.org/10.1046/j.1468-2982.1998.1806349.x
Bhatia, K.
, Brooks, D. J., Burn, D. J., Clarke, C. E., Playfer, J., Sawle, G. V., Schapira, A. H. V., Stewart, D. & Williams, A. C. (1998).
Guidelines for the management of Parkinson's disease.
Hospital Medicine,
59(6), 469-480.
Koepp, M. J., Hand, K. S. P., Labbé, C., Richardson, M. P., Van Paesschen, W., Baird, V. H., Cunningham, V. J., Bowery, N. G.
, Brooks, D. J. & Duncan, J. S. (1998).
In vivo [11C]Flumazenil-PET correlates with ex vivo [3H]Flumazenil autoradiography in hippocampal sclerosis.
Annals of Neurology,
43(5), 618-626.
https://doi.org/10.1002/ana.410430510
Morrish, P. K., Rakshi, J. S., Bailey, D. L., Sawle, G. V.
& Brooks, D. J. (1998).
Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F] dopa PET.
Journal of Neurology Neurosurgery and Psychiatry,
64(3), 314-319.
https://doi.org/10.1136/jnnp.64.3.314
Schrag, A., Rinne, J. O., Burn, D. J., Mathias, C. J., Marsden, C. D.
, Brooks, D. J. & Quinn, N. P. (1998).
Olivopontocerebellar atrophy and multiple system atrophy: Clinical follow-up of 10 patients studied with PET [4].
Annals of Neurology,
44(1), 151-152.
https://doi.org/10.1002/ana.410440133
Sabers, A., a´Rogvi-Hansen, B., Dam, M., Fischer-Rasmussen, W., Gram, L., Hansen, M.
, Møller, A. & Winkel, H. (1998).
Pregnancy and epilepsy: a retrospective study of 151 pregnancies.
Acta Neurologica Scandinavica,
97, 164-170.
Boecker, H., Dagher, A., Ceballos-Baumann, A. O., Passingham, R. E., Samuel, M., Friston, K. J., Poline, J. B., Dettmers, C., Conrad, B.
& Brooks, D. J. (1998).
Role of the human rostral supplementary motor area and the basal ganglia in motor sequence control: Investigations with H2 15O PET.
Journal of Neurophysiology,
79(2), 1070-1080.
https://doi.org/10.1152/jn.1998.79.2.1070
Rascol, O.
, Brooks, D. J., Brunt, E. R., Korczyn, A. D., Poewe, W. H. & Stocchi, F. (1998).
Ropinirole in the treatment of early Parkinson's disease: A 6-month interim report of a 5-year levodopa-controlled study.
Movement Disorders,
13(1), 39-45.
https://doi.org/10.1002/mds.870130111
Korczyn, A. D.
, Brooks, D. J., Brunt, E. R., Poewe, W. H., Rascol, O. & Stocchi, F. (1998).
Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: A 6-month interim report of a 3-year study.
Movement Disorders,
13(1), 46-51.
https://doi.org/10.1002/mds.870130112
Lawrence, A. D., Weeks, R. A.
, Brooks, D. J., Andrews, T. C., Watkins, L. H. A., Harding, A. E., Robbins, T. W. & Sahakian, B. J. (1998).
The relationship between striatal dopamine receptor binding and cognitive performance in Huntington's disease.
Brain,
121(7), 1343-1355.
https://doi.org/10.1093/brain/121.7.1343
Schrag, A. E.
, Brooks, D. J., Brunt, E., Fuell, D., Korczyn, A., Poewe, W., Quinn, N. P., Rascol, O. & Stocchi, F. (1998).
The safety of ropinirole, a selective nonergoline dopamine agonist, in patients with Parkinson's disease.
Clinical Neuropharmacology,
21(3), 169-175.
Weeks, R. A., Cunningham, V. J., Piccini, P., Waters, S., Harding, A. E.
& Brooks, D. J. (1997).
11C-diprenorphine binding in Huntington's disease: A comparison of region of interest analysis with statistical parametric mapping.
Journal of Cerebral Blood Flow and Metabolism,
17(9), 943-949.
https://doi.org/10.1097/00004647-199709000-00003
Koepp, M. J., Richardson, M. P., Labbé, C.
, Brooks, D. J., Cunningham, V. J., Ashburner, J., Van Paesschen, W., Revesz, T. & Duncan, J. S. (1997).
11C-flumazenil PET, volumetric MRI, and quantitative pathology in mesial temporal lobe epilepsy.
Neurology,
49(3), 764-773.
https://doi.org/10.1212/WNL.49.3.764
Spence, S. A.
, Brooks, D. J., Hirsch, S. R., Liddle, P. F., Meehan, J. & Grasby, P. M. (1997).
A PET study of voluntary movement in schizophrenic patients experiencing passivity phenomena (delusions of alien control).
Brain,
120(11), 1997-2011.
https://doi.org/10.1093/brain/120.11.1997
Williams, S. C. R., Simmons, A., Samuel, M., Brammer, M. J., Bullmore, E. T., Goldstein, L. H., Andrew, C. M., Andrews, C., Glover, A., Allin, M. B.
, Brooks, D. J. & Leigh, P. N. (1997).
A simple FMRI paradigm for mapping the major components of the human motor system.
NeuroImage,
5(4 PART II).
Kew, J. J. M., Halligan, P. W., Marshall, J. C., Passingham, R. E., Rothwell, J. C., Ridding, M. C., David Marsden, C.
& Brooks, D. J. (1997).
Abnormal access of axial vibrotactile input to deafferented somatosensory cortex in human upper limb amputees.
Journal of Neurophysiology,
77(5), 2753-2764.
https://doi.org/10.1152/jn.1997.77.5.2753
Jueptner, M., Stephan, K. M.
, Frith, C. D., Brooks, D. J., Frackowiak, R. S. J. & Passingham, R. E. (1997).
Anatomy of motor learning. I. Frontal cortex and attention to action.
Journal of Neurophysiology,
77(3), 1313-1324.
https://doi.org/10.1152/jn.1997.77.3.1313
Jueptner, M.
, Frith, C. D., Brooks, D. J., Frackowiak, R. S. J. & Passingham, R. E. (1997).
Anatomy of motor learning. II. Subcortical structures and learning by trial and error.
Journal of Neurophysiology,
77(3), 1325-1337.
https://doi.org/10.1152/jn.1997.77.3.1325
Ceballos-Baumann, A. O., Sheean, G., Passingham, R. E., Marsden, C. D.
& Brooks, D. J. (1997).
Botulinum toxin does not reverse the cortical dysfunction associated with writer's cramp. A PET study.
Brain,
120(4), 571-582.
https://doi.org/10.1093/brain/120.4.571
Koepp, M. J., Richardson, M. P.
, Brooks, D. J., Cunningham, V. J. & Duncan, J. S. (1997).
Central benzodiazepine/γ-aminobutyric acid(A) receptors in idiopathic generalized epilepsy: An [11C]flumazenil positron emission tomography study.
Epilepsia,
38(10), 1089-1097.
https://doi.org/10.1111/j.1528-1157.1997.tb01198.x
Nagahama, Y., Fukuyama, H., Turjanski, N., Kennedy, A., Yamauchi, H., Ouchi, Y., Kimura, J.
, Brooks, D. J. & Shibasaki, H. (1997).
Cerebral glucose metabolism in corticobasal degeneration: Comparison with progressive supranuclear palsy and normal controls.
Movement Disorders,
12(5), 691-696.
https://doi.org/10.1002/mds.870120510
Weeks, R. A., Ceballos-Baumann, A., Piccini, P., Boecker, H., Harding, A. E.
& Brooks, D. J. (1997).
Cortical control of movement in Huntington's disease. A PET activation study.
Brain,
120(9), 1569-1578.
https://doi.org/10.1093/brain/120.9.1569
Richardson, M. P., Fristen, K. J., Sisodiya, S. M., Koepp, M. J., Ashburner, J., Free, S. L.
, Brooks, D. J. & Duncan, J. S. (1997).
Cortical grey matter and benzodiazepine receptors in malformations of cortical development. A voxel-based comparison of structural and functional imaging data.
Brain,
120(11), 1961-1973.
https://doi.org/10.1093/brain/120.11.1961